A translational research initiative to revolutionize cardiovascular science through realistic simulation
The Living Heart Project aims to advance the development of safe and effective cardiovascular products and treatments by uniting engineering, scientific, and biomedical expertise to translate cutting-edge science into improved patient care. Through simulation and the creation of validated models, the project aims to provide personalized, interventional patient care.
The Living Heart Project is uniting leading cardiovascular researchers, educators, medical device developers, regulatory agencies, and practicing cardiologists on a shared mission to develop and validate highly accurate personalized digital human heart models. These models will establish a unified foundation for cardiovascular in silico medicine and serve as a common technology base for education and training, medical device design, testing, clinical diagnosis and regulatory science —creating an effective path for rapidly translating current and future cutting-edge innovations directly into improved patient care.
The Living Heart Project is driven by a growing ecosystem that is fueling the collaborative development of validated, commercially available heart models and exploring novel digital therapies. The Living Heart Project signed a five-year collaborative research agreement with the United States Food and Drug Administration (FDA). Together with the Project participants, testing paradigms beginning with the insertion, placement and performance of peacemaker leads and other cardiovascular devices will be evaluated, bringing the Living Heart Project closer to providing personalized, interventional cardiac-patient care.
There are over 90 organizations participating in the Living Heart Project which include major medical device companies, cardiologists, researchers and regulatory bodies.
With studies estimating the annual number of deaths due to medical errors in the hundreds of thousands, the time has come to revise the way the medical profession gains knowledge and experience. Advances in 3D printing technology and virtual simulation are creating new opportunities to improve the quality of treatments and patient safety.
Have you been in a situation where a generic treatment did not work very well for you or someone you know? Have you ever had that nagging feeling that maybe the doctor (as good as he or she may be) should really be treating YOU rather than a generalized representation of you?
In the US, 1 child in 68 is born with the Autism Spectrum Disorders. Children with Autism have learning and developmental disorders, and represent a number higher than all others disabilities put together. In the US alone, over 6.4% children have special needs in terms of cognitive, motor and sensory processing skills.
The satellite market has been disrupted by the miniaturization of the technology. Lots of small satellites have been created and they aim to provide data for Earth observation, surveillance, telecommunications, smart cities, connectivity, meteorology, emergency responses, ...
According to World Health Organization, 75 Million of people need a wheelchair in the world. But common wheelchair is an obsolete technology. Many situations, both professional and personal, require an adapted mobility, such as:
• People with reduced mobility whose condition requires specific measures and dedicated amenities (adaptation of post, housing, access)
Inaccurate medications kill 5 times more than road accidents in developed countries. Jus in France, they cost 10 billion euros to the public health system. Around the globe, consolidated numbers are not easily accessible but we estimate that inaccurate medications cause at least 1 million deaths and cost 1000 billion dollars to public health systems every year.
Do you think your project is the next big thing?
Join the team !